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Improving Survival for Patients With High-Risk Congenital Diaphragmatic Hernia by Using Extracorporeal Membrane Oxygenation
By F.H J.IVL vd Staak, A.F.J. de Haan, W.B. Geven, W.H. Doesburg, and C. Festen
Nijmegen, The Netherlands
• The benefit of extracorporeal membrane oxygenation 
(ECMO) in cases of high-risk congenital diaphragmatic hernia 
(CDH) was studied by comparing pre-ECMO (1987-1990) and 
post-ECMO (1991-1994) 3-month survival statistics. Fifty-five 
CDH patients who presented in respiratory distress within 6 
hours after birth were referred— 18 in the pre-ECMO era and 
37 in the ECMO era. During the entire study period (Decern 
ber 1987 through July 1994) the patients were treated by the 
same protocol of preoperative stabilization and delayed 
surgery; the only difference was the addition of ECMO 
beginning in January 1991. The patients were stratified 
based on the response to conventional treatment: 1, no 
response (irretrievable); 2, stable; 3, unstable. The 3-month 
survival rate for the unstable neonates (who could not be  
stabilized by conventional therapy) improved from 0% (0 of 
9) in the pre-ECMO era to 61% (11 of 18) in the ECMO era 
(P = .004). This highly significant difference shows that ECMO 
is a very valuable addition to the management of high-risk 
CDH patients whose conditions remain unstable despite 
maximal conventional therapy.
Copyright © 1995 by W.B. Saunders Company
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DESPITE ADVANCES in neonatal care, includ­ing prenatal diagnosis, neonatal transport, inten­sive care treatment, anesthesiology, and surgery, the 
mortality rate among infants with congenital diaphrag­
matic hernia (CDH), treated by conventional ventila­
tory management and pharmacological support, re­
mains high. The reported mortality rate for high-risk 
patients who have symptoms within 6 hours after 
birth ranges from 29% to 80% ,u9 Extracorporeal 
membrane oxygenation (ECMO) was introduced as a 
therapy for newborns with respiratory failure unre­
sponsive to maximal conventional treatment and may 
be used to support neonates who have respiratory 
distress caused by CDH ,10'12
A number of investigators have reported success in 
treating CDH with ECM O .2'4’13' 16 However, others 
have not seen improvement with use of ECMO.17,18 
According to the Extracorporeal Life Support Orga­
nization (ELSO) registry, the survival rate for CDH  
patients treated by ECMO is 58%.19 This suggests 
that ECMO has no significant impact on the survival 
of newborns with high-risk CDH.
In the present report we evaluate the role of 
ECMO in the management of CDH at our institution.
MATERIALS AND METHODS
All patients with C D H  who w ere  sym ptom atic  within 6 hours 
after birth and who were re fe r red  be tw een  D e c e m b e r  1987 and 
July 1994 were included in th e  study. All pa tien ts  w ere  trea ted  by a 
protocol of delayed surgery a f te r  p reopera tive  stabilization .5*8 
W hen  E C M O  becam e available in our  institu tion (in January  
1991), it was incorporated  into this pro tocol for C D H , w hether  
preoperatively o r  postoperatively. E C M O  was offered a f te r  conven­
tional ventilatory and m edical m an ag em en t had failed, if the  
patient fulfilled the  entry criteria  for E C M O , if the re  were no 
contraindications for E C M O , and  if p a ren ta l  consent was o b ­
tained. No infant in this study was excluded from E C M O  support  
on the basis o f  failure to achieve a m inim um  P a 02 before  the 
institution of E C M O .
Venoarteria l E C M O  was used as previously described by B a r­
tlett et a l 12 If E C M O  was requ ired  for p reopera tive  stabilization, 
the d iaphragm atic  defect was rep a ired  during  E C M O , at the end  o f  
the run, if the patient could be w eaned  from E C M O  support .20 
E C M O  was discontinued w hen resp ira to ry  failure resolved (gas 
exchange requiring PIP of less than  30, ventila tor ra tes o f  less than
40, and F ro 2 o f  less than 0.50) o r w hen a  complication arose tha t 
required cessation of E C M O  (such severe  bleeding complications 
rendering a contraindication to con tinued  heparinization). S u r ­
vival is defined as “alive at the  age of 3 m o n th s .” Survival statistics 
were com pared for two tim e periods: (1) D e c em b e r  1987 through 
D ecem ber 1990, when E C M O  was not available and all children 
were trea ted  with conventional ventila tory  support  and p h a rm aco ­
logical m anagem ent (the p re -E C M O  era, n =  18), and (2) January  
1991 through July 1994, w hen E C M O  was available and was used if 
conventional trea tm en t failed ( the  E C M O  era, n =  37).
T h e  children w ere classified into the th ree  groups described 
below.
“Irretrievable”patients. T h ese  pa tien ts  w ere (1) newborns with 
severe respiratory distress, no ted  im m ediately  a f te r  birth, in whom 
a reasonable  o r normal gas exchange was never reached , despite 
endotracheal in tubation and  artificial ventila tion , and who died 
within 2 hours after birth, befo re  E C M O  could be initiated, (2) 
newborns who died before  or during  t ran sp o rta t io n  (p re -E C M O  
era, n =  1; E C M O  era, n =  7), o r  (3) new borns with a severe 
congenital anomaly (especially chrom osom al)  for w hom  not all 
therapeutic  modalities w ere offered (p re -E C M O  era, n =  1 ).
Conventionally stabilized patients. T h ese  w ere  newborns with 
high-risk CD H , who recovered  well by (maximal) conventional 
trea tm ent and who u n d erw en t  surgical repa ir  o f  their d iaphrag­
matic defect a fte r  conventional stabilization. T hey  never m et
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E C M O -en try  criteria  befo re  rep a ir  o f their d iaphragm atic  defect 
(p re -E C M O  era, n  =  7; E C M O  era, n — 12).
Unstable patients. T h e se  w ere  newborns with high-risk CDH, 
and  who could n o t  be stabilized by maximal conventional trea tm ent 
and  who m e t  o n e  o r  m o re  E C M O -en try  criteria  (p re-E C M O  era, 
n =  9; E C M O  era , n =  18)» T h e  patients  in this category were 
subdivided into those  w ho  did  (a) or did no t (b) receive EC M O  
support.
W e  m ad e  this stratification because  we w an ted  to evaluate the 
effect o f E C M O  on  survival. T he  irretrievable patien ts  w ere in such 
distress th a t  E C M O  could  no t be  initiated before  death  o r before
4
severe brain  dam age  h ad  occurred . In these  circumstances any 
therapy, which ever applied , is doom ed  for failure. T he  availability 
o f E C M O  equ ip m en t h ad  no effect on survival, neither in this 
group n o r  in the  conventionally  stabilized patients. Because no
'  % 4p a t ien t  in the  la t te r  category m et the  E C M O -en try  criteria and 
nearly  all p a tien ts  survived, E C M O  is not a therapeutic  option for 
this group. Thus, only in th e  unstab le  pa tien ts  could the effect of 
the  availability o f E C M O  equ ipm en t be  m easured . F or compari­
sons of survival rates, th e  two-sided F isher’s Exact test was used.
RESULTS
Fifty-five newborns with high-risk CDH were evalu­
ated— 18 in the pre-ECM O era (Fig 1) and 37 in the 
ECM O era (Fig 2).
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Fig 2. Progress of 37 high-risk CDH patients in the ECMO era 
(January 1991 through July 1994).
survived. These patients would have qualified for
One patient in the pre-ECM O era was categorized ECMO support had it been available.
as ‘‘irretrievable” because of a chromosomal anomaly. Since ECMQ became available at our institution,
One neonate in the first period and seven in the latter preoperative stabilization by conventional therapy
period were irretrievable; they died o f  severe respira- could be achieved in 12 patients (Fig 2). All 12 had
tory distress shortly after birth, before ECMO could repair of their diaphragmatic defect, and 10 survived,
be or could have been initiated. In this categoxy, the although postoperative ECMO support was required
average transcutaneous oxygen saturation was 64%, for one of them.
the average P ao2 was 4.5 kilo-Pascals (kPa) (34 mm Eighteen cases were refractory to conventional
Hg), the average P a co 2 was 10.9 kPa (82m m H g)s and management and were considered for ECMO treat-
the average pH  was 6.89. ment. In two of the patients, ECMO therapy was not
In the pre-ECM O period, preoperative stabiliza- instituted; in one patient ECMO treatment was
tion could be achieved by conventional treatment 
(CT) in seven patients (Fig 1). In these patients the 
diaphragmatic defect could be repaired, and six 
survived. N ine patients could not be stabilized conven­
tionally; none of them had surgical repair, and none
Period I
n = 18
conventional treatment n -  16
immediate"!"or excluded n = 2
stable n = 7 unstable n = 9
delayed operation 
n -  7
unoperated n = 11
survived 
n = 6 t ,  n  =* 1 tn -  11
Fig 1. Progress of 18 high-risk CDH patients in the pre-ECMO era 
(December 1987 through December 1990).
refused by the parents, and in the very first patient, 
who was an ECMO candidate, we thought it was 
better to repair the diaphragmatic defect before 
initiation of ECMO, during preparation of the ECMO 
circuit. Both patients died. Thus, in 16 patients 
ECMO was used for preoperative stabilization. In 
one patient the ECMO treatment was discontinued 
because of severe cerebral bleeding, and the patient 
died without having repair of the diaphragmatic 
defect. The other 15 patients could be weaned from 
ECMO, and all had repair of their diaphragmatic 
defect during ECMO, late in the ECMO run. Eleven 
survived. The four deaths after ECMO were related 
to multiorgan failure (n =  1), severe lunghypoplasia 
(n =  1), or recurrent persistent pulmonary hyperten­
sion (n =  2). The demographic data of the different 
patient groups, for the two time periods, are reported 
in Table 1 .
The overall survival rate was 33% in the pre- 
ECMO era and 57% in the ECMO era. Excluding the 
irretrievable patients in both periods, the survival rate
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Table 1. Demographic Data for Both Time Periods
Irretrievable
Conventionally
Stable Unstable
Pre-ECMO ECMO Pre-ECMO ECMO Pre-ECMO
NOTE: Pre-ECMO era, December 1987 through December 1990; ECMO era, January 1991 through July 1994.
ECMO
Male:female ratio 0:2 4:3 3:4 5:7 5:4 10:8
Gestational age (wk)
Average 42.0 38.7 38.5 38.0 40.3 39.8
Range (42-42) (36-42) (34-41) (34-42) (38-42) (34-42)
Birth weight (g)
Average 2,850 2,740 2,780 2,660 3,160 3,410
Range (2,300-3,400) (1,500-3,460) (1,480-3,500) (1,760-3,740) (2,450-3,930) (2,560-4,175)
Apgar scores (average & range)
1 min 1.5 (1-2) 1.8 (1-4) 7.4 (4-9) 5.0 (3-9) 4.5 (1-9) 3.2 (0-6)
5 min 2,5 (1-4) 3.8 (2-6; 6.0 (4-9) 6.7 (4-10) 4.8 (1-8) 4.8 (0-8}
Side
Left: right 2:0 5:2 5:2 10:2 8:1 16:2
was 38% in the first period and 70% in the second 
period (Fisher’s Exact test, P — .08). The survival rate 
among infants who could be stabilized conventionally 
was 86% in the pre-ECMO era and 83% in the 
ECMO era (Fisher’s Exact test, P  > .50). The sur­
vival rate for the conventionally not-stabilized pa­
tients was 0% in the first period and 61% in the latter 
period (Fisher’s Exact test,P  = .004).
Ultimately, 11 of the 16 unstable patients who were 
supported by ECMO survived (69%), whereas no 
unstable patient survived without ECMO support 
(Fisher’s Exact test, P = .0006).
DISCUSSION
In this report we present our experience with 48 
severely afflicted infants with CDH, who were treated 
according to a protocol of preoperative stabilization 
and delayed surgery.5-9 This protocol was unchanged 
during the entire period of the study.
The only difference in management was the addi­
tion of ECMO for (pre- or postoperative) stabiliza­
tion since January 1991. This offers the opportunity to 
evaluate the role of ECMO in the treatment of 
high-risk CDH, by dividing the patients into two 
groups with respect to ECMO availability (pre- 
ECMO and ECMO).
The overall survival rate for high-risk CDH pa­
tients increased from 33% in the pre-ECMO era to 
57% in the ECMO era. This means improvement, but 
the difference is not significant statistically. For this 
reason, and because infants with CDH have gained 
less advantage by ECMO than have infants with 
respiratory distress from other causes,19 the benefits 
of ECMO support for high-risk CDH patients remain 
controversial.2-4*13-18 However, to assess the impact of 
ECMO we must compare identical populations with 
respect to demographic data as well as severity of 
disease, because differences in the composition of the
groups can influence the outcom e. Over the past 
decade, many attempts have been made to grade the 
seriousness o f the disease and to establish criteria by 
which survival could be predicted or by which patients 
could be considered for a certain kind of (aggressive) 
therapy. Parameters used, are the interval from birth 
until the appearance o f symptoms; the occurrence of  
a “honeymoon period”21; and blood-gas analysis, with 
and without linkage with ventilator settings and time, 
eg, A aD o 2, oxygenation index, and ventilation index 
linked with P aco2.9’22-28
Nevertheless, all criteria appear to be unreliable; 
there is no single, simple objective criterion by which 
the clinical course and outcom e can be predicted and 
by which the two interrelated pathophysiological 
mechanisms (lung hypoplasia and pulmonary hyper­
tension) can be unraveled.4»14*16*28“31 In the literature 
there is agreement that neonates who are in respira­
tory distress within 6 hours after birth constitute a 
high-risk group. We divided this high-risk group into 
three subgroups, based on the clinical course at the 
time (maximal) conventional treatment was applied.
Some patients are considered to be irretrievable 
because they are unable to attain satisfactory oxygen­
ation despite maximal conventional therapy immedi­
ately begun after birth. T hese patients have not even 
the ability to meet standard ECM O criteria because 
of lack of time. They die before ECM O can be 
initiated. Most investigators report only a few such 
cases, but these comprise 19% o f the CDH patients 
referred to our institution in the ECM O era. This 
group reflects the impact o f the availability of ECMO  
on referral patterns, but this group has a negative 
influence on the overall survival rate, which can lead 
to misinterpretation o f the efiicacy of ECMO treat­
ment in CDH  patients. The amount o f functional lung 
tissue in these infants is inadequate for survival. Since 
January 1991, 14 infants were transferred, pre- or
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postnatally, specifically for ECMO. Two could be All children who had stabilization with ECMO
treated conventionally, nine received ECMO sup- survived; this represents an increase in the overall 
port, and three died before ECMO could be initiated. survival rate. All unstable children who met ECMO 
entry criteria died without ECMO support. 
The fact that all children who met ECMO criteria
In other patients, respiratory distress can be allevi­
ated by immediate applied conventional therapy.
Some such patients can be stabilized by conventional died without ECMO support is in accordance with 
ventilatory management and never meet ECMO- the aim of ECMO as a treatment of last resort, ie, 
entry criteria. Others cannot be stabilized convention- only applied in critically ill infants, whose projected 
ally and m eet standard ECMO criteria. Only in this mortality rate was more than 80%.
latter group o f patients can a reliable judgment be 
made o f the benefit o f ECMO for CDH.
From the experience with high-risk CDH patients 
treated in our institution by a protocol of delayed
In both periods the conventionally stabilized pa- surgeiy after preoperative stabilization, with and 
tients and the unstable patients were comparable without ECMO, we draw the following conclusions, 
with respect to gestational age, birth weight, gender (1) The overall mortality rate among high-risk CDH 
distribution, Apgar scores, and side of the defect patients is still high. (2) Some infants have such 
(Table 1). As might be expected, the survival rate of severe lung hypoplasia that they were unable to attain 
category II patients was virtually the same in both sufficient gas exchange to bridge the time until 
periods— 86% in the pre-ECM O era and 83% in the initiation of ECMO. (3) U se of ECMO support is an 
ECMO era. However, the survival rate for unstable improvement in our therapy protocol for cases that 
patients is significantly better in the ECMO era than cannot be stabilized by conventional treatment; the 
it was beforehand (61% v 0%). Because the groups survival rate associated with ECMO (61%) is signifi- 
are comparable for both time periods, and because cantly better than that without ECMO (0%). (4) 
the only difference in treatment is the addition of ECMO availability changed the referral pattern;
ECMO in the latter period, the better survival rate 
can be attributed com pletely to ECMO therapy.
increasingly sicker patients are seen, who previously 
would not have survived.
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